TargetMol

Aliskiren hemifumarate

Product Code:
 
TAR-T1520
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T1520-5mg5mg£98.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1520-10mg10mg£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1520-25mg25mg£115.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1520-1mL1 mL * 10 mM (in DMSO)£120.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1520-50mg50mg£149.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1520-100mg100mg£202.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1520-200mg200mg£309.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Aliskiren Hemifumarate is an orally active nonpeptide renin inhibitor with antihypertensive activity.
CAS:
173334-58-2
Formula:
C30H53N3O6?1/2C4H4O4
Molecular Weight:
1219.6
Pathway:
Endocrinology/Hormones; Autophagy
Purity:
0.997
SMILES:
C(=O)(/C=C/C(=O)O)O.C(=O)([C@@H](C[C@@H]([C@H](C[C@@H](C(C)C)Cc1cc(c(cc1)OC)OCCCOC)N)O)C(C)C)NCC(C(=O)N)(C)C.C(=O)([C@@H](C[C@@H]([C@H](C[C@@H](C(C)C)Cc1cc(c(cc1)OC)OCCCOC)N)O)C(C)C)NCC(C(=O)N)(C)C
Target:
RAAS; Autophagy

References

1. Nakamura Y, et al. ACS Med Chem Lett, 2012, 3(9), 754?758. 2. Buczko W, et al. Pharmacol Rep, 2008, 60(5), 623-631. 3. Wood JM, et al. Biochem Biophys Res Commun, 2003, 308(4), 698-705. 4. Gradman AH, et al. Circulation, 2005, 111(8), 12012-12018. 5. Oparil S, et al. Lancet, 2007, 370(9583), 221-229.